Banque Pictet & Cie’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-69,968
Closed -$6.1M 410
2025
Q2
$6.1M Sell
69,968
-5,830
-8% -$494K 0.04% 136
2025
Q1
$6.81M Sell
75,798
-2,656
-3% -$238K 0.05% 132
2024
Q4
$6.27M Buy
78,454
+51,727
+194% +$4.48M 0.04% 137
2024
Q3
$2.41M Sell
26,727
-34,782
-57% -$2.93M 0.02% 185
2024
Q2
$4.84M Sell
61,509
-645,166
-91% -$52.9M 0.04% 150
2024
Q1
$61.6M Buy
706,675
+14,418
+2% +$1.23M 0.58% 27
2023
Q4
$57M Sell
692,257
-62,025
-8% -$4.73M 0.47% 26
2023
Q3
$59.1M Sell
754,282
-4,621
-0.6% -$387K 0.7% 24
2023
Q2
$66.9M Buy
758,903
+44,020
+6% +$3.79M 0.59% 27
2023
Q1
$57.6M Sell
714,883
-22,641
-3% -$1.85M 0.56% 27
2022
Q4
$57.3M Buy
737,524
+5,492
+0.8% +$445K 0.6% 27
2022
Q3
$59.1M Sell
732,032
-1,622
-0.2% -$146K 0.64% 25
2022
Q2
$65.8M Buy
733,654
+7,137
+1% +$723K 0.65% 27
2022
Q1
$80.6M Buy
726,517
+9,493
+1% +$1M 0.62% 24
2021
Q4
$74.2M Buy
717,024
+50,879
+8% +$5.89M 0.55% 29
2021
Q3
$83.5M Buy
666,145
+27,127
+4% +$3.51M 0.87% 21
2021
Q2
$79.3M Sell
639,018
-8,147
-1% -$1.02M 0.88% 20
2021
Q1
$76.5M Sell
647,165
-49,177
-7% -$5.76M 0.98% 20
2020
Q4
$81.6M Buy
696,342
+7,511
+1% +$827K 1.11% 19
2020
Q3
$71.6M Buy
688,831
+55,992
+9% +$5.62M 1.08% 20
2020
Q2
$58M Buy
632,839
+69,543
+12% +$6.67M 0.97% 21
2020
Q1
$50.8M Buy
563,296
+29,272
+5% +$3.11M 1.05% 19
2019
Q4
$60.6M Buy
+534,024
New +$58.6M 1.05% 21
2015
Q1
Sell
-4,300
Closed -$310K 485
2014
Q4
$310K Hold
4,300
0.01% 362
2014
Q3
$266K Hold
4,300
0.01% 389
2014
Q2
$274K Sell
4,300
-811
-16% -$49.3K 0.01% 382
2014
Q1
$315K Buy
5,111
+561
+12% +$32.7K 0.01% 345
2013
Q4
$261K Buy
+4,550
New +$258K 0.01% 304

Other funds holding MDT

Banque Pictet & Cie's MDT Position: Q3 2025 in Review

Banque Pictet & Cie sold out of Medtronic (MDT) in Q3 2025, closing a stake of 69,968 shares — an estimated $6.1M sold.

Banque Pictet & Cie first reported a position in MDT in Q4 2013 and held it in 28 quarters. The position peaked at $83.5M in Q3 2021. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Banque Pictet & Cie reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Banque Pictet & Cie sold 69,968 Medtronic shares in Q3 2025, an estimated $6.1M.
  • Banque Pictet & Cie first reported a position in Medtronic in Q4 2013 and held it in 28 quarters.
  • Banque Pictet & Cie's Medtronic position peaked at $83.5M in Q3 2021.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Banque Pictet & Cie's 13F filing for Q3 2025, filed 21 Oct 2025.